News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current TCON market cap is 87.37M. The company's latest EPS is USD -0.0788 and P/E is -23.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 9M | 0 |
| Operating Income | -6.38M | -5.83M | -7.31M | -779k | -1.59M |
| Net Income | -6.44M | -7M | -8.5M | -6.29M | 10.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 346k | 0 | 12.05M |
| Operating Income | -22.3M | -16.22M | -28.35M | -27.89M | -9.27M |
| Net Income | -22.67M | -16.78M | -28.67M | -29.14M | -3.59M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.67M | 19.47M | 8.32M | 12.19M | 9.41M |
| Total Liabilities | 22.3M | 26.62M | 19.4M | 27.93M | 12.5M |
| Total Equity | -2.64M | -7.15M | -11.07M | -15.74M | -3.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 18.12M | 37.44M | 26.56M | 19.47M | 10.11M |
| Total Liabilities | 15.42M | 12.37M | 14.84M | 26.62M | 10.91M |
| Total Equity | 2.7M | 25.07M | 11.71M | -7.15M | -809k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.59M | -26.24M | -5M | -10.85M | 4.2M |
| Investing | -13k | -17k | N/A | N/A | N/A |
| Financing | 14.74M | 19.68M | -5.82M | -4.77M | -13.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.65M | -17.04M | -22.57M | -26.24M | 3.68M |
| Investing | 14.02M | -4M | 3.95M | -17k | N/A |
| Financing | 906k | 36.76M | 10.56M | 19.68M | -12.54M |
| Market Cap | 87.37M |
| Price to Earnings Ratio | -23.48 |
| Price to Sales Ratio | 6.99 |
| Price to Cash Ratio | 9.83 |
| Price to Book Ratio | -104.06 |
| Dividend Yield | - |
| Shares Outstanding | 45.5M |
| Average Volume (1 week) | 560.56k |
| Average Volume (1 Month) | 2.63M |
| 52 Week Change | -94.55% |
| 52 Week High | 36.80 |
| 52 Week Low | 1.59 |
| Spread (Intraday) | 0.18 (9.09%) |
| Company Name | TRACON Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.traconpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
